Italian study tracks new combo therapy for advanced lung cancer in everyday practice
NCT ID NCT07190677
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Italian study is collecting real-world data from 300 patients with advanced non-small cell lung cancer who are receiving a combination of nivolumab, ipilimumab, and chemotherapy as their first treatment. The goal is to see how long patients live and how long the cancer stays under control in everyday clinical settings, not just in clinical trials. Researchers are also tracking side effects and how well the treatment works in different patient groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- nivolumab plus ipilimumab plus chemotherapy
- What this could lead to
- If successful, this study could confirm that this drug combination works well in real-world patients, not just in controlled trials.
- What could go wrong
- This is an observational study, not a controlled experiment, so results may be less reliable. It also only includes patients in Italy, which may limit how well findings apply elsewhere.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, Lombardy, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple-drug cocktail re-sensitize lung cancer to treatment?
- Could a lung cancer drug designed for one mutation work for another?
- Could chemo plus immunotherapy double the punch against tough lung cancers?
- Should all advanced lung cancer patients get a brain scan? new trial aims to find out
- New hope for tough lung cancer? trial tests targeted drug against chemo
- New combo therapy for lung cancer under Real-World watch